Dr. Christopher Lee, Investment Analyst, Capital Group
Dr. Lee is an investment analyst with Capital Group with research responsibility for U.S. pharmaceuticals and biotechnology. He has 11 years of investment industry experience, four of which have been with Capital Group. Prior to joining Capital, Chris worked as a portfolio manager/analyst at Franklin Templeton. He has invested in companies across all stages, both public and private.
Chris began his career at McKinsey & Company, advising healthcare companies in the U.S. and Europe.Chris holds a doctor of medicine degree from Columbia University and a bachelor's degree in molecular biophysics and biochemistry from Yale University. He graduated from Polytechnic School in Pasadena, CA.